Android app Apple app link

BridgeBio Pharma, Inc. (BBIO) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$40.07

$1.07 (-2.6%)
Last update: 04:00 PM EST
Day's range
$39.9
Day's range
$41.12

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
04/30/2025 UBS Eliana Merle $72.00 $38.36   87.7%
10/24/2024 Citigroup David Lebowitz $45.00 $24.17   86.18%
10/17/2024 Leerink Partners Mani Foroohar $46.00 $26.34   74.64%
09/11/2024 Piper Sandler Biren Amin $46.00 $28.78   59.83%
09/03/2024 Mizuho Securities Salim Syed $53.00 $29.92   77.14%
06/24/2024 Raymond James Danielle Brill $46.00 $22.65   103.14%
06/05/2024 BMO Capital Kostas Biliouris $37.00 $26.93   37.42%
06/05/2024 Wells Fargo Tiago Fauth $58.00 $27.13   113.79%
05/30/2024 Goldman Sachs Paul Choi $50.00 $27.61   81.09%
05/28/2024 UBS Eliana Merle $47.00 $27.94   68.22%
05/20/2024 H.C. Wainwright Raghuram Selvaraju $43.00 $30.09   42.9%
05/13/2024 Evercore ISI Cory Kasimov $50.00 $28.50   75.44%

BridgeBio Pharma, Inc. FAQ's

BridgeBio Pharma, Inc. has been rated by research analysts at UBS, Citigroup, Leerink Partners, Piper Sandler, Mizuho Securities, Raymond James in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.